GlassScriptPhysician profile
Henrietta L Mayuga
NPI 1497719256
$4,640.71
in general payments reported to CMS, 2019-2025
36 companies · $932 in 2025
The $932 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $88.71 · 2021: $560 · 2022: $603 · 2023: $719 · 2024: $1,085 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,672 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,671.57 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,114.02 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $785.43 | 2019-2025 | Farxiga |
| Pfizer INC. | $448.68 | 2021-2025 | |
| Novo Nordisk INC | $328.79 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.52 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $200.98 | 2021-2024 | Shingrix, Bexsero, Arexvy |
| Lilly USA, LLC | $193.94 | 2021-2024 | Jardiance, Mounjaro, Zepbound |
| Exeltis, USA INC. | $151.23 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $115.99 | 2019-2022 | |
| Astellas Pharma US INC | $87.21 | 2024-2025 | Veozah |
| Sanofi Pasteur INC. | $77.21 | 2021-2023 | |
| Exact Sciences Corporation | $71.48 | 2023-2024 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $67.87 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $62.10 | 2022 | |
| Corcept Therapeutics | $57.74 | 2025 | Korlym |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henrietta Mayuga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.